Uptake Medical (2216)

Executive Summary

Uptake Medical is a private medical device company dedicated to improving the lives of patients with pulmonary disease through its proprietary vapor ablation technology. Based in Eindhoven, Netherlands (with operations also in San Jose, CA), the company was founded in 2004 and focuses on bronchoscopic lung volume reduction (BLVR) for severe COPD/emphysema, as well as ablation of lung tumors. Its InterVapor system uses heated water vapor to precisely target and shrink diseased lung tissue, offering a minimally invasive alternative to surgery or radiation. The technology has received CE marking and is commercially available in select European markets, while the company continues to pursue regulatory approvals and clinical evidence expansion to drive adoption. Uptake Medical's approach addresses a significant unmet need in respiratory care, potentially improving lung function, exercise capacity, and quality of life for patients who are not candidates for traditional therapies. With a strong intellectual property portfolio and growing clinical data, the company is positioned for growth pending key regulatory and commercial milestones.

Upcoming Catalysts (preview)

• Q2 2027FDA Approval for InterVapor in Severe COPD/Emphysema70% success
• Q4 2026Publication of Pivotal Trial Results for Lung Cancer Ablation60% success
• Q1 2027Strategic Partnership or Distribution Agreement in Asia-Pacific50% success